期刊
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 33, 期 2, 页码 251-260出版社
WILEY
DOI: 10.1111/j.1365-2036.2010.04513.x
关键词
-
资金
- Takeda Pharmaceuticals
- National Institute on Aging [R01-AG034676]
P>Background Although direct medical costs for constipation-related medical visits are thought to be high, to date, there have been no studies examining longitudinal resource utilisation in adults with constipation. Aim To estimate the incremental direct medical costs associated with constipation in women. Methods This is a nested case-control study. The study population consisted of all mothers of 5718 children in the population-based birth cohort born during 1976-1982 in a community. The cases presented to the medical facilities with constipation. The controls were randomly selected and matched to cases in a 2:1 ratio. Direct medical costs for constipated women and controls were collected for the years 1987-2002. Results We identified 168 women with a diagnosis of constipation. The total direct medical costs over the 15-year period for constipated subjects were more than double those of controls [$63 591 (95% CI: 49 786-81 396) vs. $24 529 (95% CI: 20 667-29 260)]. The overall out-patient costs for constipated women were $38 897 (95% CI: 31 381-48 253) compared to $15 110 (95% CI: 12 904-17 781) for controls. The median of annual out-patient visits for constipated women was 0.16 compared to 0.11 for controls. Conclusion Women with constipation have significantly higher medical care utilisation and expenditures compared with women without constipation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据